These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 7694847
1. Stimulation of oxytocin release in the lactating rat by a central interaction of alpha 1-adrenergic and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-sensitive excitatory amino acid mechanisms. Parker SL, Crowley WR. Endocrinology; 1993 Dec; 133(6):2855-60. PubMed ID: 7694847 [Abstract] [Full Text] [Related]
2. Stimulation of oxytocin release in the lactating rat by central excitatory amino acid mechanisms: evidence for specific involvement of R,S-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-sensitive glutamate receptors. Parker SL, Crowley WR. Endocrinology; 1993 Dec; 133(6):2847-54. PubMed ID: 7694846 [Abstract] [Full Text] [Related]
3. Central stimulation of oxytocin release in the lactating rat: interaction of neuropeptide Y with alpha-1-adrenergic mechanisms. Parker SL, Crowley WR. Endocrinology; 1993 Feb; 132(2):658-66. PubMed ID: 8381069 [Abstract] [Full Text] [Related]
4. Central stimulation of oxytocin release in the lactating rat by N-methyl-D-aspartate: requirement for coactivation through non-NMDA glutamate receptors or the glycine coagonist site. Parker SL, Crowley WR. Neuroendocrinology; 1995 Nov; 62(5):467-78. PubMed ID: 8559278 [Abstract] [Full Text] [Related]
12. Evidence for involvement of an adrenal catecholamine in the beta-adrenergic inhibition of oxytocin release in lactating rats. Song SL, Crowley WR, Grosvenor CE. Brain Res; 1988 Aug 09; 457(2):303-9. PubMed ID: 2851365 [Abstract] [Full Text] [Related]
13. Electrophysiological effects of kainic acid on vasopressin-enhanced green fluorescent protein and oxytocin-monomeric red fluorescent protein 1 neurones isolated from the supraoptic nucleus in transgenic rats. Ohkubo J, Ohbuchi T, Yoshimura M, Maruyama T, Ishikura T, Matsuura T, Suzuki H, Ueta Y. J Neuroendocrinol; 2014 Jan 09; 26(1):43-51. PubMed ID: 24341559 [Abstract] [Full Text] [Related]
14. Roles of the spinal glutamatergic pathway activated through α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors and its interactions with spinal noradrenergic and serotonergic pathways in the rat urethral continence mechanisms. Kawamorita N, Kaiho Y, Miyazato M, Arai Y, Yoshimura N. Neurourol Urodyn; 2015 Jun 09; 34(5):475-81. PubMed ID: 24668912 [Abstract] [Full Text] [Related]
15. Evidence for stimulatory noradrenergic and inhibitory dopaminergic regulation of oxytocin release in the lactating rat. Crowley WR, Shyr SW, Kacsoh B, Grosvenor CE. Endocrinology; 1987 Jul 09; 121(1):14-20. PubMed ID: 3109879 [Abstract] [Full Text] [Related]
16. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. Pittaluga A, Raiteri M. J Pharmacol Exp Ther; 1992 Jan 09; 260(1):232-7. PubMed ID: 1370540 [Abstract] [Full Text] [Related]
17. Effect of magnesium sulfate on excitatory amino acid receptors in the rat brain. II. Kainate and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Hallak M, Irtenkauf SM, Cotton DB. Am J Obstet Gynecol; 1996 Sep 09; 175(3 Pt 1):582-7. PubMed ID: 8828417 [Abstract] [Full Text] [Related]
18. Angiotensin II-induced release of oxytocin: interaction with norepinephrine and role in lactation. Bealer SL, Crowley WR. Regul Pept; 2003 Mar 28; 111(1-3):41-6. PubMed ID: 12609747 [Abstract] [Full Text] [Related]
19. Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate. Lin TH, Yang RS, Tang CH, Wu MY, Fu WM. Eur J Pharmacol; 2008 Jul 28; 589(1-3):37-44. PubMed ID: 18538763 [Abstract] [Full Text] [Related]
20. Regional decreases in alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) and 6-[3H]cyano-7-nitroquinoxaline-2,3-dione ([3H]CNQX) binding in response to chronic low-level lead exposure: reversal versus potentiation by chronic dopamine agonist treatment. McCoy L, Richfield EK, Cory-Slechta DA. J Neurochem; 1997 Dec 28; 69(6):2466-76. PubMed ID: 9375679 [Abstract] [Full Text] [Related] Page: [Next] [New Search]